...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Equity offering
5
Jun 04, 2018 04:39PM
3
Jun 04, 2018 04:51PM
4
Jun 04, 2018 05:21PM
4
Jun 04, 2018 07:05PM

Shares on the market for $2.50 US hope to raise $10,000,000.

 

Share
New Message
Please login to post a reply